top of page

FDA-IND Application for Expanded Use & NDC Registrations 01/01/2022

  • Jan 25, 2022
  • 1 min read

Updated: Feb 1, 2024

FDA-IND Application for Intermediate Size Group Population Expanded Access:

1. Outline of Materials

2. FDA-IND-1571: Expanded Access Form

3. Financial Interests of Investigator Form

4. Statement of Investigators Form

5. Principal Investigator & Co-PI CV

6. Statement of Purpose, Background

7. Proposed Research Project Background

8. Current Provisional Patent Claims

9. Clinical Design, Aims, Goals & Budget

10. Research Validation Brain Imaging

11. Research Consent, IND Disclosures

12. Formula: Pharmacology-Toxicology Data

13. Current Thesis Research Outline

14. Commercial Pitch Deck with Societal Impact Statement, Referenced Background, Commercial Potentials Real Time Revenue Model






 
 
 

Comments


Neuroscience Institute on Addiction  Recovery

  • Facebook
  • YouTube

© 2023-2030 Website & Brand is a Registered USPTO for All Copyrights,

Trademarks, Patents & International Publications 

All Rights Reserved

USPTO-FDA-NIH-NCBI-NLM-PUBMED-CMS-DHS-DOD-DARPA

Vetted Registered Clearance Identification Numbers:

USGOV-SAM-SBIR: JAC6JJKYAF77JJ / DUN#: 013428223 / CAGE: 8TT10 / NAICS: 541611 

NATIONAL PROVIDER NUMBERS (NPIs): 1467193623/1083355119

Due Diligence Disclosure Reviews, Alignments & Match Verifications:

UNITED STATES GOVERNMENT: FDA. SBIR, NIH, USPTO, FEDERAL NIH-NIDA RFA, DoD CAGE-NAICS, GRANTS.GOV,

DUN & BRADSTREET, STATE LLC-501c3 REGISTRATION, TOP TEIR INSURANCE CARRIER CONTRACT CREDENTIALED,

ETHEREUM, FACEBOOK-META-MULTIVERSE-NFT, PAYPAL & VENMO CORPORATE, BANK OF AMERICA CORPORATE ZELLE,

AMAZON VETTED PARTNERSHIP BUSINESS

bottom of page